Glioma-derived CSF-1 not only acts as chemoattractant but also induces a shift of microglia and macrophages toward a pro-tumor phenotype, and blocking CSF-1 receptor (CSF-1R) inhibits alternative activation of TAMs and attenuates glioma progression [30]. Here, CSF1R is linked to neoplasm.